MHC Class II

Measuring Immunity: Basic Biology and Clinical Assessment

Volumn , Issue , 2005, Pages 12-22

  Chow, Amy Y ^a   Unternaehrer, Julia J ^a   Mellman, Ira ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882881090     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012455900-4/50264-6     Document Type: Chapter

References (118)

1. Ackerman A.L., Kyritsis C., Tampe R., Cresswell P. Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens. Proc Natl Acad Sci USA 2003, 100:12889-12894.
2. Adorini L., Nagy Z.A. Peptide competition for antigen presentation. Immunol Today 1990, 11:21-24.
3. Al-Daccak R., Mooney N., Charron D. MHC class II signaling in antigen-presenting cells. Curr Opin Immunol 2004, 16:108-113.
4. Amigorena S., Drake J.R., Webster P., Mellman I. Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature 1994, 369:113-120.
5. Amigorena S., Webster P., Drake J., Newcomb J., Cresswell P., Mellman I. Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles. J Exp Med 1995, 181:1729-1741.
6. Anderson H., Hiltbold E., Roche P. Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation. Nat Immunol 2000, 1:156-162.
7. Andreae S., Buisson S., Triebel F. MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223). Blood 2003, 102:2130-2137.
8. Angelisova P., Hilgert I., Horejsi V. Association of four antigens of the tetraspans family (CD37, CD53, TAPA-1, and R2/C33) with MHC class II glycoproteins. Immunogenetics 1994, 39:249-256.
9. Antoniou A.N., Blackwood S.L., Mazzeo D., Watts C. Control of antigen presentation by a single protease cleavage site. Immunity 2000, 12:391-398.
10. Arunachalam B., Phan U.T., Geuze H.J., Cresswell P. Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT). Proc Natl Acad Sci USA 2000, 97:745-750.
11. Bakke O., Dobberstein B. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 1990, 63:707-716.
12. Bania J., Gatti E., Lelouard H., et al. Human cathepsin S, but not cathepsin L, degrades efficiently MHC class II-associated invariant chain in nonprofessional APCs. Proc Natl Acad Sci USA 2003, 100:6664-6669.
13. Belz G.T., Carbone F.R., Heath W.R. Crosspresentation of antigens by dendritic cells. Crit Rev Immunol 2002, 22:439-448.
14. Benaroch P., Yilla M., Raposo G., et al. How MHC class II molecules reach the endocytic pathway. EMBO J 1995, 14:37-49.
15. Bertho N., Blancheteau V.M., Setterblad N., et al. MHC class II-mediated apoptosis of mature dendritic cells proceeds by activation of the protein kinase C-delta isoenzyme. Int Immunol 2002, 14:935-942.
16. Bikoff E.K., Jaffe L., Ribaudo R.K., Otten G.R., Germain R.N., Robertson E.J. MHC class I surface expression in embryo-derived cell lines inducible with peptide or interferon. Nature 1991, 354:235-238.
17. Boes M., Cerny J., Massol R., et al. T-cell engagement of dendritic cells rapidly rearranges MHC class II transport. Nature 2002, 418:983-988.
18. Boss J.M. Regulation of transcription of MHC class II genes. Curr Opin Immunol 1997, 9:107-113.
19. Bouillon M., El Fakhry Y., Girouard J., Khalil H., Thibodeau J., Mourad W. Lipid raft-dependent and-independent signaling through HLA-DR molecules. J Biol Chem 2003, 278:7099-7107.
20. Brown J.H., Jardetzky T.S., Gorga J.C., et al. Threedimensional structure of the human class II histocompatibility antigen HLA-DR1 (see comments). Nature 1993, 364:33-39.
21. Busch R., Rothbard J.B. Detection of peptide-MHC class II complexes on the surface of intact cells. J Immunol Methods 1990, 134:1-22.
22. Castellino F., Zappacosta F., Coligan J.E., Germain R.N. Large protein fragments as substrates for endocytic antigen capture by MHC class II molecules. J Immunol 1998, 161:4048-4057.
23. Cella M., Engering A., Pinet V., Pieters J., Lanzavecchia A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 1997, 388:782-787.
24. Chaput N., Schartz N.E., Andre F., Zitvogel L. Exosomes for immunotherapy of cancer. Adv Exp Med Biol 2003, 532:215-221.
25. Cherry R.J., Wilson K.M., Triantafilou K., et al. Detection of dimers of dimers of human leukocyte antigen (HLA)-DR on the surface of living cells by single-particle fluorescence imaging. J Cell Biol 1998, 140:71-79.
26. Chmielowski B., Pacholczyk R., Kraj P., Kisielow P., Ignatowicz L. Presentation of antagonist peptides to naive CD4+ T cells abrogates spatial reorganization of class II MHC peptide complexes on the surface of dendritic cells. Proc Natl Acad Sci USA 2002, 99:15012-15017.
27. Chow A., Toomre D., Garrett W., Mellman I. Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane. Nature 2002, 418:988-994.
28. Cresswell P. Assembly, transport, and function of MHC class II molecules. Ann Rev Immunol 1994, 12:259-293.
29. Dausset J., Rapaport F. Transplantation Biology: Cellular and Molecular Aspects 1996, Lippincott-Raven Publishers, Philadelphia, New York.
30. Davidson H.W., Reid P.A., Lanzavecchia A., Watts C. Processed antigen binds to newly synthesized MHC class II molecules in antigen-specific B lymphocytes. Cell 1991, 67:105-116.
31. Deng H., Apple R., Clare-Salzler M., et al. Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease. J Exp Med 1993, 178:1675-1680.
32. Denzin L.K., Cresswell P. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell 1995, 82:155-165.
33. Denzin L.K., Sant'Angelo D.B., Hammond C., Surman M.J., Cresswell P. Negative regulation by HLA-DO of MHC class II-restricted antigen processing. Science 1997, 278:106-109.
34. Dustin M.L., Bromley S.K., Kan Z., Peterson D.A., Unanue E.R. Antigen receptor engagement delivers a stop signal to migrating T lymphocytes. Proc Natl Acad Sci USA 1997, 94:3909-3913.
35. Dustin M.L., Springer T.A. T-cell receptor crosslinking transiently stimulates adhesiveness through LFA-1. Nature 1989, 341:619-624.
36. Engering A., Pieters J. Association of distinct tetraspanins with MHC class II molecules at different subcellular locations in human immature dendritic cells. Int Immunol 2001, 13:127-134.
37. Fink P.J., Bevan M.J. Positive selection of thymocytes. Adv Immunol 1995, 59:99-133.
38. Fremont D.H., Dai S., Chiang H., Crawford F., Marrack P., Kappler J. Structural basis of cytochrome c presentation by IE(k). J Exp Med 2002, 195:1043-1052.
39. Fremont D.H., Hendrickson W.A., Marrack P., Kappler J. Structures of an MHC class II molecule with covalently bound single peptides. Science 1996, 272:1001-1004.
40. Fremont D.H., Monnaie D., Nelson C.A., Hendrickson W.A., Unanue E.R. Crystal structure of I-Ak in complex with a dominant epitope of lysozyme. Immunity 1998, 8:305-317.
41. Gorer P.A. The genetic and antigenic basis of tumour transplantation. J Pathol of Bacterical 1937, 44:691-697.
42. Gould D.S., Auchincloss H. Direct and indirect recognition: the role of MHC antigens in graft rejection. Immunol Today 1999, 20:77-82.
43. Guermonprez P., Saveanu L., Kleijmeer M., Davoust J., Van Endert P., Amigorena S. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 2003, 425:397-402.
44. Guermonprez P., Valladeau J., Zitvogel L., Thery C., Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 2002, 20:621-667.
45. Hampl J., Chien Y.H., Davis M.M. CD4 augments the response of a T cell to agonist but not to antagonist ligands. Immunity 1997, 7:379-385.
46. Harding C.V., Geuze H.J. Class II MHC molecules are present in macrophage lysosomes and phagolysosomes that function in the phagocytic processing of Listeria monocytogenes for presentation to T cells. J Cell Biol 1992, 119:531-542.
47. Hauss P., Selz F., Cavazzana-Calvo M., Fischer A. Characteristics of antigen-independent and antigendependent interaction of dendritic cells with CD4+ T cells. Eur J Immunol 1995, 25:2285-2294.
48. Hawiger D., Inaba K., Dorsett Y., et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 2001, 194:769-779.
49. Hiltbold E.M., Poloso N.J., Roche P.A. MHC class II-peptide complexes and APC lipid rafts accumulate at the immunological synapse. J Immunol 2003, 170:1329-1338.
50. Houde M., Bertholet S., Gagnon E., et al. Phagosomes are competent organelles for antigen cross-presentation. Nature 2003, 425:402-406.
51. Huby R., Chowdhury F., Lombardi G. Rafts for antigen presentation?. Nat Immunol 2001, 2:3.
52. Inaba K., Steinman R.M. Monoclonal antibodies to LFA-1 and to CD4 inhibit the mixed leukocyte reaction after the antigen-dependent clustering of dendritic cells and T lymphocytes. J Exp Med 1987, 165:1403-1417.
53. Inaba K., Turley S., Iyoda T., et al. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J Exp Med 2000, 191:927-936.
54. Janeway C.A., Travers P., Walport M., Shlomchik M. Immunobiology: The Immune System in Health and Disease 2001, Garland Publishing, New York and London. 5th edn.
55. Jenei A., Varga S., Bene L., et al. HLA class I and II antigens are partially co-clustered in the plasma membrane of human lymphoblastoid cells. Proc Natl Acad Sci USA 1997, 94:7269-7274.
56. Kleijmeer M.J., Morkowski S., Griffith J.M., Rudensky A.Y., Geuze H.J. Major histocompatibility complex class II compartments in human and mouse B lymphoblasts represent conventional endocytic compartments. J Cell Biol 1997, 139:639-649.
57. Kleijmeer M., Ramm G., Schuurhuis D., et al. Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells. J Cell Biol 2001, 155:53-63.
58. Koch N., van Driel I.R., Gleeson P.A. Hijacking a chaperone: manipulation of the MHC class II presentation pathway. Immunol Today 2000, 21:546-550.
59. Kropshofer H., Spindeldreher S., Rohn T.A., et al. Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes. Nat Immunol 2002, 3:61-68.
60. Krummel M., Wulfing C., Sumen C., Davis M.M. Thirty-six views of T-cell recognition. Philos Trans R Soc Lond B Biol Sci 2000, 355:1071-1076.
61. Kuby J. Immunology 1997, W.H. Freeman and Company, New York.
62. Lake R.A., Robinson B.W., Hayball J.D. MHC multimerization, antigen expression and the induction of APC amnesia in the developing immune response. Immunol Cell Biol 1999, 77:99-104.
63. Landmann S., Muhlethaler-Mottet A., Bernasconi L., et al. Maturation of dendritic cells is accompanied by rapid transcriptional silencing of class II transactivator (CIITA) expression. J Exp Med 2001, 194:379-391.
64. Lechler R., Aichinger G., Lightstone L. The endogenous pathway of MHC class II antigen presentation. Immunol Rev 1996, 151:51-79.
65. Lich J.D., Elliott J.F., Blum J.S. Cytoplasmic processing is a prerequisite for presentation of an endogenous antigen by major histocompatibility complex class II proteins. J Exp Med 2000, 191:1513-1524.
66. Mahnke K., Guo M., Lee S., et al. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J Cell Biol 2000, 151:673-684.
67. Manoury B., Mazzeo D., Li D.N., et al. Asparagine endopeptidase can initiate the removal of the MHC class II invariant chain chaperone. Immunity 2003, 18:489-498.
68. Maric M., Arunachalam B., Phan U.T., et al. Defective antigen processing in GILT-free mice. Science 2001, 294:1361-1365.
69. McDevitt H.O. Discovering the role of the major histocompatibility complex in the immune response. Annu Rev Immunol 2000, 18:1-17.
70. McFarland B.J., Beeson C. Binding interactions between peptides and proteins of the class II major histocompatibility complex. Med Res Rev 2002, 22:168-203.
71. Medawar P.B. Notes on the problem of skin homografts. Bull War Med 1943, 4:1-4.
72. Mellman I., Steinman R.M. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001, 106:255-258.
73. Monks C.R., Freiberg B.A., Kupfer H., Sciaky N., Kupfer A. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 1998, 395:82-86.
74. Nakagawa T., Roth W., Wong P., et al. Cathepsin L: critical role in li degradation and CD4 T cell selection in the thymus. Science 1998, 280:450-453.
75. Nakagawa T.Y., Brissette W.H., Lira P.D., et al. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity 1999, 10:207-217.
76. Nepom G.T., Erlich H. MHC class-II molecules and autoimmunity. Annu Rev Immunol 1991, 9:493-525.
77. Nestle F.O., Banchereau J., Hart D. Dendritic cells: On the move from bench to bedside. Nat Med 2001, 7:761-765.
78. Odorizzi C.G., Trowbridge I.S., Xue L., Hopkins C.R., Davis C.D., Collawn J.F. Sorting signals in the MHC class II invariant chain cytoplasmic tail and transmembrane region determine trafficking to an endocytic processing compartment. J Cell Biol 1994, 126:317-330.
79. Pathak S.S., Blum J.S. Endocytic recycling is required for the presentation of an exogenous peptide via MHC class II molecules. Traffic 2000, 1:561-569.
80. Peters P.J., Neefjes J.J., Oorschot V., Ploegh H.L., Geuze H.J. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature 1991, 349:669-676.
81. Phan U.T., Arunachalam B., Cresswell P. Gammainterferon-inducible lysosomal thiol reductase (GILT). Maturation, activity, and mechanism of action. J Biol Chem 2000, 275:25907-25914.
82. Pierre P., Denzin L.K., Hammond C., et al. HLA-DM is localized to conventional and unconventional MHC class II-containing endocytic compartments. Immunity 1996, 4:229-239.
83. Pierre P., Mellman I. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell 1998, 93:1135-1145.
84. Pierre P., Turley S.J., Gatti E., et al. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 1997, 388:787-792.
85. Pieters J., Bakke O., Dobberstein B. The MHC class II-associated invariant chain contains two endosomal targeting signals within its cytoplasmic tail. J Cell Sci 1993, 106:831-846.
86. Pinet V., Vergelli M., Martin R., Bakke O., Long E.O. Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature 1995, 375:603-606.
87. Raposo G., Nijman H.W., Stoorvogel W., et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med 1996, 183:1161-1172.
88. Reich Z., Altman J.D., Boniface J.J., et al. Stability of empty and peptide-loaded class II major histocompatibility complex molecules at neutral and endosomal pH: comparison to class I proteins. Proc Natl Acad Sci USA 1997, 94:2495-2500.
89. Riese R.J., Wolf P.R., Bromme D., et al. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 1996, 4:357-366.
90. Roche P.A., Marks M.S., Cresswell P. Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature 1991, 354:392-394.
91. Roosnek E., Demotz S., Corradin G., Lanzavecchia A. Kinetics of MHC-antigen complex formation on antigen-presenting cells. J Immunol 1988, 140:4079-4082.
92. Roucard C., Garban F., Mooney N.A., Charron D.J., Ericson M.L. Conformation of human leukocyte antigen class II molecules. Evidence for superdimers and empty molecules on human antigen presenting cells. J Biol Chem 1996, 271:13993-14000.
93. Rubinstein E., Le Naour F., Lagaudriere-Gesbert C., Billard M., Conjeaud H., Boucheix C. CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins. Eur J Immunol 1996, 26:2657-2665.
94. Rudensky A., Preston-Hurlburt P., Hong S.C., Barlow A., Janeway C.A. Sequence analysis of peptides bound to MHC class II molecules. Nature 1991, 353:622-627.
95. Salamero J., Humbert M., Cosson P., Davoust J. Mouse B lymphocyte specific endocytosis and recycling of MHC class II molecules. EMBO J 1990, 9:3489-3496.
96. Schafer P.H., Pierce S.K. Evidence for dimers of MHC class II molecules in B lymphocytes and their role in low affinity T cell responses. Immunity 1994, 1:699-707.
97. Schick M.R., Levy S. The TAPA-1 molecule is associated on the surface of B cells with HLA-DR molecules. J Immunol 1993, 151:4090-4097.
98. Sercarz E.E., Maverakis E. Mhc-guided processing: binding of large antigen fragments. Nat Rev Immunol 2003, 3:621-629.
99. Setum C.M., Serie J.R., Hegre O.D. Dendritic cell/lymphocyte clustering: morphologic analysis by transmission electron microscopy and distribution of gold-labeled MHC class II antigens by high-resolution scanning electron microscopy. Anat Res 1993, 235:285-295.
100. Shaw A.S., Dustin M.L. Making the T cell receptor go the distance: a topological view of T cell activation. Immunity 1997, 6:361-369.
101. Smilek D.E., Wraith D.C., Hodgkinson S., Dwivedy S., Steinman L., McDevitt H.O. A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 1991, 88:9633-9637.
102. Starzl T.E., Murase N., Demetris A., Trucco M., Fung J. The mystique of hepatic tolerogenicity. Semin Liver Dis 2000, 20:497-510.
103. Starzl T.E., Murase N., Abu-Elmagd K., et al. Tolerogenic immunosuppression for organ transplantation 2003, 361:1502-1510.
104. Steimle V., Siegrist C.A., Mottet A., Lisowska-Grospierre B., Mach B. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 1994, 265:106-109.
105. Szollosi J., Horejsi V., Bene L., Angelisova P., Damjanovich S. Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY. J Immunol 1996, 157:2939-2946.
106. Tabata H., Matsuoka T., Endo F., Nishimura Y., Matsushita S. Ligation of HLA-DR molecules on B cells induces enhanced expression of IgM heavy chain genes in association with Syk activation. J Biol Chem 2000, 275:34998-35005.
107. Thery C., Zitvogel L., Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002, 2:569-579.
108. Triebel F. LAG-3: a regulator of T-cell and DC responses and its use in therapeutic vaccination. Trends Immunol 2003, 24:619-622.
109. Trombetta E.S., Ebersold M., Garrett W., Pypaert M., Mellman I. Activation of lysosomal function during dendritic cell maturation. Science 2003, 299:1400-1403.
110. Tulp A., Verwoerd D., Dobberstein B., Ploegh H.L., Pieters J. Isolation and characterization of the intracellular MHC class II compartment. Nature 1994, 369:120-126.
111. Turley S.J., Inaba K., Garrett W.S., et al. Transport of peptide-MHC class II complexes in developing dendritic cells. Science 2000, 288:522-527.
112. Watts C. Capture and processing of exogenous antigens for presentation on MHC molecules. Ann Rev Immunol 1997, 15:821-850.
113. Watts C. Antigen processing in the endocytic compartment. Curr Opin Immunol 2001, 13:26-31.
114. Wetzel S.A., McKeithan T.W., Parker D.C. Live-cell dynamics and the role of costimulation in immunological synapse formation. J Immunol 2002, 169:6092-6101.
115. Wulfing C., Sumen C., Sjaastad M.D., Wu L.C., Dustin M.L., Davis M.M. Costimulation and endogenous MHC ligands contribute to T cell recognition. Nat Immunol 2002, 3:42-47.
116. Zinkernagel R.M., Doherty P.C. The discovery of MHC restriction. Immunol Today 1997, 18:14-17.
117. Zitvogel L., Angevin E., Tursz T. Dendritic cell-based immunotherapy of cancer. Ann Oncol 2000, 11(Suppl 3):199-205.
118. Zitvogel L., Regnault A., Lozier A., et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med 1998, 4:594-600.